Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
Globe Newswire (Wed, 29-Apr 6:00 AM ET)
Kestra Showcases Accelerated Innovation at HRS 2026
Globe Newswire (Wed, 22-Apr 8:00 AM ET)
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
Globe Newswire (Thu, 9-Apr 8:00 AM ET)
Kestra Medical Technologies Named Finalist for 2026 GeekWire "Deal of the Year"
Globe Newswire (Wed, 25-Mar 8:00 AM ET)
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
Globe Newswire (Tue, 17-Mar 4:01 PM ET)
Market Chameleon (Wed, 3-Dec 5:34 AM ET)
KMTS to Reveal Q2 Fiscal 2026 Results: Key Dates and What Investors Should Watch
Market Chameleon (Wed, 3-Dec 3:59 AM ET)
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Kestra Medical Techs trades on the NASDAQ stock market under the symbol KMTS.
As of June 12, 2026, KMTS stock price climbed to $20.85 with 351,890 million shares trading.
KMTS has a beta of 2.06, meaning it tends to be more sensitive to market movements. KMTS has a correlation of 0.12 to the broad based SPY ETF.
KMTS has a market cap of $1.22 billion. This is considered a Small Cap stock.
Last quarter Kestra Medical Techs reported $25 million in Revenue and -$.61 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.01.
The top ETF exchange traded funds that KMTS belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
KMTS has underperformed the market in the last year with a return of +11.2%, while the SPY ETF gained +24.1%. In the last 3 month period, KMTS fell short of the market, returning +9.6%, while SPY returned +11.6%. However, in the most recent 2 weeks KMTS has outperformed the stock market by returning -1.9%, while SPY returned -1.9%.
KMTS support price is $19.07 and resistance is $21.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMTS shares will trade within this expected range on the day.